Alimuddin Zumla
Impact in
- Infectious Diseases top 0.01%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 0.05%
- COVID-19 epidemiological studies
Papers in
-
- Tuberculosis Research and Epidemiology 249
- SARS-CoV-2 and COVID-19 Research 50
- Viral Infections and Outbreaks Research 39
- Epidemiology 199
- Mycobacterium research and diagnosis 72
- Pneumocystis jirovecii pneumonia detection and treatment 68
- Pneumonia and Respiratory Infections 43
- Co-authors
- David S.C. Hui (33 shared papers)Keertan Dheda (36 shared papers)Jim F. Huggett (27 shared papers)Ziad A. Memish (53 shared papers)Stephen A. Bustin (3 shared papers)Markus Maeurer (95 shared papers)G.A.W. Rook (34 shared papers)Esam I. Azhar (39 shared papers)
- Journals
- International Journal of Infectious Diseases (84 papers)The Lancet Infectious Diseases (57 papers)The Lancet (41 papers)Current Opinion in Pulmonary Medicine (26 papers)The Lancet Respiratory Medicine (20 papers)
- Partner nations
- United KingdomUnited StatesZambia
In The Last Decade
Alimuddin Zumla
619 papers receiving 36.8k citations
Alimuddin Zumla's Hit Papers
Peers
Comparison fields: 5 of 215
- Infectious Diseases 19.2k
- Modeling and Simulation 1.9k
- Epidemiology 9.2k
- Virology 1.2k
- Applied Microbiology and Biotechnology 267
Countries citing papers authored by Alimuddin Zumla
This map shows the geographic impact of Alimuddin Zumla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alimuddin Zumla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alimuddin Zumla more than expected).
Fields of papers citing papers by Alimuddin Zumla
This network shows the impact of papers produced by Alimuddin Zumla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alimuddin Zumla. The network helps show where Alimuddin Zumla may publish in the future.
Co-authors
The 25 scholars most cited alongside Alimuddin Zumla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 636 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Real-time RT-PCR normalisation; strategies and considerations Hit paper breakdown → | 2005 | 1530 |
| 2 | Coronaviruses — drug discovery and therapeutic options Hit paper breakdown → | 2016 | 1298 |
| 3 | Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Hit paper breakdown → | 2013 | 1052 |
| 4 | Middle East respiratory syndrome Hit paper breakdown → | 2015 | 946 |
| 5 | Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus Hit paper breakdown → | 2013 | 894 |
| 6 | Validation of housekeeping genes for normalizing RNA expression in real-time PCR Hit paper breakdown → | 2004 | 827 |
| 7 | Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts Hit paper breakdown → | 2021 | 702 |
| 8 | Advances in the development of new tuberculosis drugs and treatment regimens Hit paper breakdown → | 2013 | 700 |
| 9 | Tuberculosis Hit paper breakdown → | 2011 | 575 |
| 10 | Mandell, Douglas, and Bennett's principles and practice of infectious diseases Hit paper breakdown → | 2010 | 561 |
| 11 | The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization Hit paper breakdown → | 2005 | 553 |
| 12 | Tuberculosis Hit paper breakdown → | 2013 | 531 |
| 13 | Human Monkeypox Hit paper breakdown → | 2019 | 451 |
| 14 | Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis Hit paper breakdown → | 2010 | 415 |
| 15 | Immunological biomarkers of tuberculosis Hit paper breakdown → | 2011 | 392 |
| 16 | Severe Acute Respiratory Syndrome Hit paper breakdown → | 2019 | 364 |
| 17 | Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test Hit paper breakdown → | 2013 | 358 |
| 18 | The WHO 2014 Global tuberculosis report—further to go Hit paper breakdown → | 2014 | 354 |
| 19 | 2010 | 352 | |
| 20 | Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections Hit paper breakdown → | 2013 | 345 |
About Alimuddin Zumla
Alimuddin Zumla is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Surgery and Immunology, having authored 636 papers that have together received 37.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (249 papers), Mycobacterium research and diagnosis (72 papers), Pneumocystis jirovecii pneumonia detection and treatment (68 papers), Diagnosis and treatment of tuberculosis (52 papers), SARS-CoV-2 and COVID-19 Research (50 papers), Infectious Diseases and Tuberculosis (45 papers), Pneumonia and Respiratory Infections (43 papers) and Viral Infections and Outbreaks Research (39 papers). The work is most often cited by research in Infectious Diseases (19.2k citations), Modeling and Simulation (1.9k citations), Epidemiology (9.2k citations), Virology (1.2k citations) and Applied Microbiology and Biotechnology (267 citations). Alimuddin Zumla has collaborated with scholars based in United Kingdom, United States and Zambia. Frequent co-authors include David S.C. Hui, Keertan Dheda, Jim F. Huggett, Ziad A. Memish, Stephen A. Bustin, Markus Maeurer, G.A.W. Rook, Esam I. Azhar, Peter Mwaba and Stanley Perlman. Their work appears in journals such as International Journal of Infectious Diseases, The Lancet Infectious Diseases, The Lancet, Current Opinion in Pulmonary Medicine and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.